qPCR Instruments Market Size

The global qPCR instruments market size was valued at around USD 1.6 billion in 2023 and is estimated to grow at a CAGR of 8.4% from 2024 to 2032. The increasing prevalence of diseases worldwide and the rising emphasis on personalized medicine are driving the growth of the market.

The increasing prevalence of diseases globally is a major factor in this growth, as real-time quantification tools are critical for diagnosing and monitoring infectious diseases, cancer, and genetic disorders. qPCR's ability to provide rapid, accurate results makes it indispensable in disease detection, particularly in regions facing rising rates of infections and chronic conditions. Factors contributing to the increasing prevalence of diseases include urbanization, aging populations, and lifestyle changes that heighten the risk of non-communicable diseases. According to the World Health Organization (WHO), non-communicable diseases now account for 74% of global deaths, increasing the demand for advanced diagnostic tools like qPCR.

Additionally, the rising emphasis on personalized medicine is further propelling the qPCR instruments market, as qPCR enables precise genetic profiling and real-time monitoring, which are critical for tailoring treatments to individual patients. Personalized medicine relies on accurate molecular diagnostics to identify genetic mutations and biomarkers, making qPCR an essential tool in optimizing patient care. As the demand for individualized therapies grows, qPCR’s role in drug development, companion diagnostics, and targeted treatments continues to expand, driving market growth.

qPCR (quantitative Polymerase Chain Reaction) instruments are advanced laboratory devices used to amplify and simultaneously quantify a specific DNA or RNA sequence in real time. These instruments combine thermal cycling with fluorescence-based detection, enabling accurate quantification of nucleic acids during the amplification process.